|
1
|
Benedict M and Zhang X: Non-alcoholic
fatty liver disease: An expanded review. World J Hepatol.
9:715–732. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gusdon AM, Song KX and Qu S: Nonalcoholic
Fatty liver disease: Pathogenesis and therapeutics from a
mitochondria-centric perspective. Oxid Med Cell Longev.
2014:6370272014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Besse-Patin A and Estall JL: An intimate
relationship between ROS and insulin signalling: Implications for
antioxidant treatment of fatty liver disease. Int J Cell Biol.
2014:5191532014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mello T, Materozzi M and Galli A: PPARs
and mitochondrial metabolism: From NAFLD to HCC. PPAR Res.
2016:74032302016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bravo E, Palleschi S, Rossi B, Napolitano
M, Tiano L, D'Amore E and Botham KM: Coenzyme Q metabolism is
disturbed in high fat diet-induced non-alcoholic fatty liver
disease in rats. Int J Mol Sci. 13:1644–1657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schweitzer A, Horn J, Mikolajczyk RT,
Krause G and Ott JJ: Estimations of worldwide prevalence of chronic
hepatitis B virus infection: A systematic review of data published
between 1965 and 2013. Lancet. 386:1546–1555. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu A, Lai CL and Yuen MF: Update on the
risk of hepatocellular carcinoma in chronic hepatitis B virus
infection. Curr Hepat Rep. 10:106–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tu T, Budzinska MA, Shackel NA and Urban
S: HBV DNA integration: Molecular Mechanisms and Clinical
Implications. Viruses. 9(pii): E752017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Joo EJ, Chang Y, Yeom JS and Ryu S:
Hepatitis B virus infection and decreased risk of nonalcoholic
fatty liver disease: A cohort study. Hepatology. 65:828–835. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He J, Zeng YL, Li W, Guo EE, Li JL, Kang Y
and Shang J: Clinical study of non-alcoholic fatty liver disease
and its combined the chronic HBV infection. Zhonghua Gan Zang Bing
Za Zhi. 25:618–622. 2017.(In Chinese). PubMed/NCBI
|
|
11
|
Lin HJ, Ku KL, Lin IH and Yeh CC:
Naringenin attenuates hepatitis B virus X protein-induced hepatic
steatosis. BMC Complement Altern Med. 17:5052017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bouchard MJ and Schneider RJ: The
enigmatic X gene of hepatitis B virus. J Virol. 78:12725–12734.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen HY, Tang NH, Lin N, Chen ZX and Wang
XZ: Hepatitis B virus X protein induces apoptosis and cell cycle
deregulation through interfering with DNA repair and checkpoint
responses. Hepatol Res. 38:174–182. 2008.PubMed/NCBI
|
|
14
|
Na TY, Shin YK, Roh KJ, Kang SA, Hong I,
Oh SJ, Seong JK, Park CK, Choi YL and Lee MO: Liver X receptor
mediates hepatitis B virus X protein-induced lipogenesis in
hepatitis B virus-associated hepatocellular carcinoma. Hepatology.
49:1122–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH,
Moon HB, Kim HH, Yang US, Yu DY and Cheong J: Hepatitis B virus X
protein induces hepatic steatosis via transcriptional activation of
SREBP1 and PPARgamma. Gastroenterology. 132:1955–1967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SJ, Khan M, Quan J, Till A, Subramani
S and Siddiqui A: Hepatitis B virus disrupts mitochondrial
dynamics: Induces fission and mitophagy to attenuate apoptosis.
PLoS Pathog. 9:e10037222013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valkov I, Ivanova R, Alexiev A, Antonov K
and Mateva L: Association of serum lipids with hepatic steatosis,
stage of liver fibrosis and viral load in chronic Hepatitis C. J
Clin Diagn Res. 11:OC15–OC20. 2017.PubMed/NCBI
|
|
18
|
Chen J, Zhang W, Lin J, Wang F, Wu M, Chen
C, Zheng Y, Peng X, Li J and Yuan Z: An efficient antiviral
strategy for targeting hepatitis B virus genome using transcription
activator-like effector nucleases. Mol Ther. 22:303–311. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB
and Chen Y: Hepatitis B virus X protein promotes hepatocellular
carcinoma transformation through interleukin-6 activation of
microRNA-21 expression. Eur J Cancer. 50:2560–2569. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gong S, Peng Y, Jiang P, Wang M, Fan M,
Wang X, Zhou H, Li H, Yan Q, Huang T and Guan MX: A
deafness-associated tRNAHis mutation alters the mitochondrial
function, ROS production and membrane potential. Nucleic Acids Res.
42:8039–8048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JS, Sharma LK, Li H, Xiang R,
Holstein D, Wu J, Lechleiter J, Naylor SL, Deng JJ, Lu J and Bai Y:
A heteroplasmic, not homoplasmic, mitochondrial DNA mutation
promotes tumorigenesis via alteration in reactive oxygen species
generation and apoptosis. Hum Mol Genet. 18:1578–1589. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma LK, Fang H, Liu J, Vartak R, Deng J
and Bai Y: Mitochondrial respiratory complex I dysfunction promotes
tumorigenesis through ROS alteration and AKT activation. Hum Mol
Genet. 20:4605–4616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen L, Fan JG, Shao Y, Zeng MD, Wang JR,
Luo GH, Li JQ and Chen SY: Prevalence of nonalcoholic fatty liver
among administrative officers in Shanghai: An epidemiological
survey. World J Gastroenterol. 9:1106–1110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi
SL, Chen MH and Hu PJ: Prevalence of fatty liver disease and its
risk factors in the population of South China. World J
Gastroenterol. 13:6419–6424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim HY, Cho HK, Yoo SK and Cheong JH:
Hepatic STAMP2 decreases hepatitis B virus X protein-associated
metabolic deregulation. Exp Mol Med. 44:622–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Satapati S, Kucejova B, Duarte JA,
Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu
X, et al: Mitochondrial metabolism mediates oxidative stress and
inflammation in fatty liver. J Clin Invest. 125:4447–4462. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ringelhan M, O'Connor T, Protzer U and
Heikenwalder M: The direct and indirect roles of HBV in liver
cancer: Prospective markers for HCC screening and potential
therapeutic targets. J Pathol. 235:355–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual report to the nation on the status of cancer,
1975-2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar R and Boon-Bee Goh G: Chronic
hepatitis B and fatty liver: Issues in clinical management. Clin
Res Hepatol Gastroenterol. 40:755–759. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang CC and Kao JH: Hepatitis B virus
infection and decreased risk of nonalcoholic fatty liver disease: A
cohort study. Hepatology. 66:6812017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wong VW, Wong GL, Chu WC, Chim AM, Ong A,
Yeung DK, Yiu KK, Chu SH, Chan HY, Woo J, et al: Hepatitis B virus
infection and fatty liver in the general population. J Hepatol.
56:533–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng YL, Wang YJ, Kao WY, Chen PH, Huo
TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, et al: Inverse
association between hepatitis B virus infection and fatty liver
disease: A large-scale study in populations seeking for check-up.
PLoS One. 8:e720492013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Z, Xu M, Hu Z and Shrestha UK:
Prevalence of nonalcoholic fatty liver disease and its metabolic
risk factors in women of different ages and body mass index.
Menopause. 22:667–673. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN
and Lin X: Hepatitis B Virus X protein induces hepatic steatosis by
enhancing the expression of liver fatty acid binding protein. J
Virol. 90:1729–1740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim K, Kim KH, Kim HH and Cheong J:
Hepatitis B virus X protein induces lipogenic transcription factor
SREBP1 and fatty acid synthase through the activation of nuclear
receptor LXRalpha. Biochem J. 416:219–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nassir F and Ibdah JA: Role of
mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci.
15:8713–8742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu L, Zhang K, Sandoval H, Yamamoto S,
Jaiswal M, Sanz E, Li Z, Hui J, Graham BH, Quintana A and Bellen
HJ: Glial lipid droplets and ROS induced by mitochondrial defects
promote neurodegeneration. Cell. 160:177–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weinberg F, Hamanaka R, Wheaton WW,
Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger
GR and Chandel NS: Mitochondrial metabolism and ROS generation are
essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA.
107:8788–8793. 2010. View Article : Google Scholar : PubMed/NCBI
|
